Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Attorney Spotlight: Angela Humphreys

April 10, 2015

Angela HumphreysTell us about your practice. 

I focus my practice on healthcare mergers and acquisitions and operations. My clients include start-up companies, private equity firms and their portfolio companies, as well as publicly traded companies. A substantial part of my practice is focused on private equity backed middle-market companies, and I serve as the outside general counsel for a number of my clients.

What is an interesting trend happening right now related to your field of practice? 

We are seeing a lot of activity in the urgent care, dermatology and dental practice spaces. These transactions typically involve physician practices and can be quite complex, particularly around corporate practice of medicine issues, management fee structures and tax reorganizations designed to afford the buyer the ability to maintain a tax identification number for reimbursement purposes. Being able to work with clients in the structuring of transactions is one of my favorite aspects of my practice. 

In March 2015 you assumed leadership of the firm's healthcare practice. How have your years of practicing law prepared you for this new role? 

I have practiced law going on 20 years. During that time, I have learned that our firm consistently distinguishes itself with the promise of unmatched responsiveness and client service – and we deliver. I look forward to working with our group to continue to deliver and capitalize on that promise. Our group is at an exciting juncture. With almost 40 regulatory lawyers in Nashville, an office in D.C., and a specialty pharmacy practice headquartered in Memphis, we are poised to further grow our national healthcare practice.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.